Search research articles
Contact Us
Filters
Showing results (81-90 of 249) with videos related to
Page
of 25
Sort By:
Journal of Dairy Science
|
February 16, 2023
Factors associated with intensity of technology adoption and with the adoption of 4 clusters of precision livestock farming technologies in Irish pasture-based dairy systems
P Palma-Molina, T Hennessy, A H O'Connor, et al.
Frontiers in Oncology
|
February 16, 2023
Review of the status of neoadjuvant therapy in HER2-positive breast cancer
Gavin P Dowling, Stephen Keelan, Sinead Toomey, et al.
The Journal of Physical Chemistry. A
|
July 16, 2008
Evidence for Rydberg doorway states in photoion pair formation in bromomethane
Trevor Ridley, John T Hennessy, Robert J Donovan, et al.
Cancer Research
|
June 4, 2009
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression
Rachelle L Dillon, Richard Marcotte, Bryan T Hennessy, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
March 25, 2011
Quantitative proteomic analysis in breast cancer
A Tabchy, B T Hennessy, A M Gonzalez-Angulo, et al.
Journal of the American Chemical Society
|
December 28, 2019
A Modular and Diastereoselective 5 + 1 Cyclization Approach to N-(Hetero)Aryl Piperidines
Matthew A Larsen, Elisabeth T Hennessy, Madeleine C Deem, et al.
Oncogene
|
November 8, 2011
Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest
P Russell, B T Hennessy, J Li, et al.
BMC Bioinformatics
|
December 24, 2008
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays
Romesh Stanislaus, Mark Carey, Helena F Deus, et al.
Cancer
|
February 7, 2009
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer
Asif Loya, Merih Guray, Bryan T Hennessy, et al.
Breast Cancer Research and Treatment
|
December 22, 2014
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
N Elster, M Cremona, C Morgan, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 249) with videos related to
Sort By:
Page
of 25
Journal of Dairy Science
|
February 16, 2023
Factors associated with intensity of technology adoption and with the adoption of 4 clusters of precision livestock farming technologies in Irish pasture-based dairy systems
P Palma-Molina, T Hennessy, A H O'Connor, et al.
Frontiers in Oncology
|
February 16, 2023
Review of the status of neoadjuvant therapy in HER2-positive breast cancer
Gavin P Dowling, Stephen Keelan, Sinead Toomey, et al.
The Journal of Physical Chemistry. A
|
July 16, 2008
Evidence for Rydberg doorway states in photoion pair formation in bromomethane
Trevor Ridley, John T Hennessy, Robert J Donovan, et al.
Cancer Research
|
June 4, 2009
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression
Rachelle L Dillon, Richard Marcotte, Bryan T Hennessy, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
March 25, 2011
Quantitative proteomic analysis in breast cancer
A Tabchy, B T Hennessy, A M Gonzalez-Angulo, et al.
Journal of the American Chemical Society
|
December 28, 2019
A Modular and Diastereoselective 5 + 1 Cyclization Approach to N-(Hetero)Aryl Piperidines
Matthew A Larsen, Elisabeth T Hennessy, Madeleine C Deem, et al.
Oncogene
|
November 8, 2011
Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest
P Russell, B T Hennessy, J Li, et al.
BMC Bioinformatics
|
December 24, 2008
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays
Romesh Stanislaus, Mark Carey, Helena F Deus, et al.
Cancer
|
February 7, 2009
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer
Asif Loya, Merih Guray, Bryan T Hennessy, et al.
Breast Cancer Research and Treatment
|
December 22, 2014
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
N Elster, M Cremona, C Morgan, et al.
Page
of 25